抗 SMV 栽培大豆种质资源的 SCAR 标记指纹图谱分析

依据与ＳＭＶ（ＳｏｙｂｅａｎＭｏｓａｉｃＶｉｒｕｓ）抗性基因紧密连锁的共显性ＳＣＡＲ标记ＳＣＷ—０５６６０的序列测定结果，合成了两对ＳＣＡＲ（ＳｅｑｕｅｎｃｅＣｈａｒａｃｔｅｒｉｚｅｄＡｍｐｌｉｆｉｅｄＲｅ－ｇｉｏｎｓ）标记特异引物，对３０个栽培大豆品种进行了指纹图谱分析。结果表明，较短的片段Ｓ—５６００和Ｓ—０５６６０是抗病品种的特征性条带；而较长的片段Ｓ—５１０００和Ｓ—５１６００是感病品种的特征性条带。Ｓｏｕｔｈｅｒｎ杂交结果表明，这两对引物扩增出的条带具有同源性。     

文摘（2）

文摘（２）ｌ高能量废弃爆炸物的回收处理（英文）Ｃ９４２９３１５２ＴＯＲＭＡＳＣ（ＯｌｉｎＯｒｄｎａｎｃｅ，ＦＬ），ＲＩＳＥＲＢ（ＮａｔｉｏｎａｌＯｒｄｎａｎｃｅａｎｄＭｕｍ－ｂ。ｕｓＥｎ川ｒ。＂ｍｅｎ比ＩＴｅｓｔｃｅｎ忱ｒ，ＡＲ），ＴＯＲＭＡＡＥ（Ｅ...     

最新分析方法缩略语

最新分析方法缩略语ＡＦＭ－ＡｔｏｍｉｃＦｏｒｃｅＭｉｃｒｏｓｃｏｐｅ原子力显微镜ＡＭ－ＡｃｏｕｓｔｉｃＭｉｃｒｏｓｃｏｐｙ声学显微术ＥＳ－ＥｍｉｓｓｉｏｎＳｐｅｃｔｒｏｓｃｏｐｙ发射光谱术ＥＳＣＡ－ＥｌｅｃｔｒｏｎＳｐｅｃｔｒｏｓｃｏｐｙｆｏｒＣｈａ...     

最新分析方法缩略语EI

最新分析方法缩略语ＡＦＭ－ＡｔｏｍｉｃＦｏｒｃｅＭｉｃｒｏｓｃｏｐｅ原子力显微镜ＡＭ－ＡｃｏｕｓｔｉｃＭｉｃｒｏｓｃｏｐｙ声学显微术ＥＳ－ＥｍｉｓｓｉｏｎＳｐｅｃｔｒｏｓｃｏｐｙ发射光谱术ＥＳＣＡ－ＥｌｅｃｔｒｏｎＳｐｅｃｔｒｏｓｃｏｐｙｆｏｒＣｈａ...     

常压MOCVD制备MgO薄膜的研究

本文首次报道用常压金属有机化学气相沉积（ＡＰ－ＭＯＣＶＤ）在Ｓｉ（１００），ＳｉＯ２／Ｓｉ（１００）和Ｐｔ／Ｓｉ（１００）衬底上外延高质量的ＭｇＯ薄膜。研究了衬底温度与薄膜的取向性关系和ＭｇＯ薄膜的潮解特性。高纯ｍａｇｎｅｓｉｕｍａｃｅｔｙｌａｃｅｔｏｎａｔｅ［ｂｉｓ（２，４－ｐｅｎｔａｎｅｔａｎｅ－ｄｉｏｎｏ）ｍａｇｎｅｓｉｕｍ］［Ｍｇ（ＣＨ２ＣＯＣＨ２ＣＯＣＨ３）２］作为金属有机源，扫描电镜（ＳＥＭ），透射电镜（ＴＥＭ）和Ｘ－ＲＡＹ衍射实验显示，在较低的衬底温度（～４８０℃）下一次淀积成单晶膜。薄膜均匀，致密，结晶性和取向性很好，衬底温度（Ｔｓ）在４００℃到６８０℃之间，在Ｓｉ（１００）衬底上生长的ＭｇＯ薄膜都具有［１００］取向，在Ｓｉ（１００）、ＳｉＯ２／Ｓｉ（１００）和Ｐｔ／Ｓｉ（１００）衬底上生长的ＭｇＯ薄膜也都具有［１００］取向。     

酵母人工染色体载体的改造和修饰

将能在植物中表达的烟草花叶病毒ＣａＭＶ３５Ｓ启动子、ＧＵＳ基因、潮霉素（Ｈｙｇｒｏｍｙｃｉｎ）基因及ＭＯＳ终止子组建到酵母人工染色体（ＹＡＣ）载体，构建了具有能在植物细胞中表达和选择ｐＹＡＶ、ＧＵＳ、ｐＪＳ９７／ｐＪＳ９８－ＨＹ ＹＡＣ载体系体系统和一个标记ＹＡＣ克隆的ｐＵＲ４３－ＨＹ质粒。     

二价离子替代的Nasicon及其应用研究

含二价阳离子的Ｎａｓｉｃｏｎ，Ｍ￣（２＋）Ｎａｓｉｃｏｎ（Ｍ＝Ｍｇ、Ｃａ、Ｓｒ、Ｚｎ）可由母体Ｎａ＿３Ｚｒ＿２Ｓｉ＿２ＰＯ＿（１２）（Ｎａｓｉｃｏｎ）为起始原料与相应的二价离子的盐浓液或熔盐进行离子交换而制得。Ｘ射线衍射分析结果表明离子交换后的产物Ｍ￣（２＋）－Ｎａｓｉｃｏｎ大多保持原母体的Ｃ＿（２／ｃ）结构。交流阻抗技术测定的电导率数据显示含不同的二价替代离子的Ｎａｓｉｃｏｎ的电导率相差甚大。其中最好的是Ｍｇ￣（２＋）－Ｎａｓｉｃｏｎ，其电导率在４００℃时可达到１．４８×１０￣（－２）Ｓ／ｃｍ。Ｍｇ￣（２＋）－Ｎａｓｉｃｏｎ用作微功率固态电池Ｍｇ／ＣｕＣｌ的电解质，该电池的开路电压为２．０７Ｖ，短路电流为１ｍＡ。平均放电电压为１．６Ｖ，电池的放电容量是３．４ｍＡＨ。     

国产中型活塞式制冷机的新进展与选用探讨

国产中型活塞式制冷机的新进展与选用探讨ＡｄｖａｎｃｅｍｅｎｔａｎｄＣｈｏｏｓｉｎｇｏｎＭｉｄｄｌｅ－ＳｉｚｅＲｅｃｉｐｒｏｃａｔｉｎｇＣｏｍｐｒｅｓｓｏｒｓ张建一（集美大学水产学院制冷教研室厦门３６１０２１）随着我国经济建设的发展和人民生活水平的提高...     

A Modification of SOM Network(SLFM) and Its Applications in Tool Wear Monitoring and Quality Control

ＡＭｏｄｉｆｉｃａｔｉｏｎｏｆＳＯＭＮｅｔｗｏｒｋ（ＳＬＦＭ）ａｎｄＩｔｓＡｐｐｌｉｃａｔｉｏｎｓｉｎＴｏｏｌＷｅａｒＭｏｎｉｔｏｒｉｎｇａｎｄＱｕａｌｉｔｙＣｏｎｔｒｏｌ★ＺｈｕＭｉｎｇｑｕａｎＣａｉＹｏｎｇｘｉａＤｅｐａｒｔｍｅｎｔｏｆＡｅｒｏｎ...     

研制直9新材料 逐步实现国产化EI

研制直９新材料逐步实现国产化哈尔滨飞机制造公司廖美东ＲｅｓｅａｒｃｈｏｎＮｅｗＭａｔｅｒｉａｌｓｏｆＺ９ａｎｄＢｅｃｏｍｉｎｇＳｅｌｆ－ＳｕｆｆｃｉｅｎｔＬｉａｏＭｅｉｄｏｎｇ（ＨａｒｂｉｎＡｉｒｃｒａｆｔＩｎｄｕｓｔｒｉａｌＣｏｍｐａｎｙ）引进法国...     

Molecular imaging of advanced atherosclerotic plaques with folate receptor-targeted 2D nanoprobes

Vulnerable atherosclerotic plaques are responsible for most cardiovascular diseases (CVDs). Folate receptor (FR) positive activated macrophages were thought to be a prominent component in the development of vulnerable plaque. The objective of this study is to develop folate conjugated two-dimensional (2D) Pd@Au nanomaterials (Pd@Au-PEG-FA) for targeted multimodal imaging of the FRs in advanced atherosclerotic plaques. Pharmacokinetic and imaging studies (single photon emission computed tomography (SPECT), computed tomography (CT) and photoacoustic (PA) imaging) were performed to confirm the prolonged blood half-life and enrichment of radioactivity in atherosclerotic plaques. Strong signals were detected in vivo with SPECT, CT and PA imaging in heavy atherosclerotic plaques, which were significantly higher than those of the normal aortas after injection of Pd@Au-PEG-FA. Blocking studies with preinjection of excess FA could effectively reduce the targeting ability of Pd@Au-PEG-FA in atherosclerotic plaques, further demonstrating the specific binding of Pd@Au-PEG-FA for plaque lesions. Histopathological characterization revealed that the signal of probe was in accordance with the high-risk plaques. In summary, the Pd@Au-PEG-FA has favorable pharmacokinetic properties and provides a valuable approach for detecting high-risk plaques in the presence of FRs in atherosclerotic plaques.

     

Recent Advances in Managing Atherosclerosis via Nanomedicine

Atherosclerosis, driven by chronic inflammation of the arteries and lipid accumulation on the blood vessel wall, underpins many cardiovascular diseases with high mortality rates globally, such as stroke and ischemic heart disease. Engineered bio‐nanomaterials are now under active investigation as carriers of therapeutic and/or imaging agents to atherosclerotic plaques. This Review summarizes the latest bio‐nanomaterial‐based strategies for managing atherosclerosis published over the past five years, a period marked by a rapid surge in preclinical applications of bio‐nanomaterials for imaging and/or treating atherosclerosis. To start, the biomarkers exploited by emerging bio‐nanomaterials for targeting various components of atherosclerotic plaques are outlined. In addition, recent efforts to rationally design and screen for bio‐nanomaterials with the optimal physicochemical properties for targeting plaques are presented. Moreover, the latest preclinical applications of bio‐nanomaterials as carriers of imaging, therapeutic, or theranostic agents to atherosclerotic plaques are discussed. Finally, a mechanistic understanding of the interactions between bio‐nanomaterials and the plaque (“athero–nano” interactions) is suggested, the opportunities and challenges in the clinical translation of bio‐nanomaterials for managing atherosclerosis are discussed, and recent clinical trials for atherosclerotic nanomedicines are introduced.     

Polarization-sensitive optical coherence tomography for imaging human atherosclerosis

Polarization-sensitive optical coherence tomography (PS-OCT) combines the advantages of OCT with image contrast enhancement, which is based on its ability to detect phase retardation and the fast-axis angle. Both PS-OCT images and histopathology have demonstrated similar features that allowed differentiation of atherosclerotic structures (i.e., plaques) from normal tissue. Moreover, the picrosirius polarization method was used to confirm PS-OCT assessment of collagen in the fibrous cap of atherosclerotic plaques, and high-frequency (40 MHz) ultrasound images were used to identify calcium in the vessel wall. Our preliminary ex vivo investigation of human aortic specimens indicated that PS-OCT might help to identify atherosclerotic lesions.     

Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques

To detect macrophages in atherosclerotic plaques, plasmonic gold nanoparticles are introduced as a contrast agent for intravascular photoacoustic imaging. The phantom and ex vivo tissue studies show that the individual spherical nanoparticles, resonant at 530 nm wavelength, produce a weak photoacoustic signal at 680 nm wavelength while photoacoustic signal from nanoparticles internalized by macrophages is very strong due to the plasmon resonance coupling effect. These results suggest that intravascular photoacoustic imaging can assess the macrophage-mediated aggregation of nanoparticles and therefore identify the presence and the location of nanoparticles associated with macrophage-rich atherosclerotic plaques.     

超声消融动脉粥样硬化斑块的研究

超声消融动脉粥样硬化斑块是一种介入式超声治疗方法，通过金属丝将超声能量入因斑块所致的血管狭窄或完全堵塞处，使斑块消融实现血管内腔扩大或再通，消融斑块的碎片不会造成远端血管的再堵塞。     

Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging

The need for more specific and selective contrast agents for magnetic resonance imaging motivated us to prepare a new nanoparticle agent based on high-density lipoproteins (HDL). This second generation contrast agent can be prepared in three different ways. The HDL nanoparticles (rHDL) were fully characterized by FPLC and gel electrophoresis. The flexibility of the platform also allows us to incorporate optical probes into rHDL for localization ex vivo by confocal fluorescence microscopy. The contrast-agent-containing nanoparticles were injected into mice that develop atherosclerotic lesions. Magnetic resonance imaging of the animals showed clear enhancement of the atherosclerotic plaques.     

Intravascular photoacoustic imaging using an IVUS imaging catheter

Catheter-based imaging of atherosclerosis with high resolution, albeit invasive, is extremely important for screening and characterization of vulnerable plaques. Currently, there is a need for an imaging technique capable of providing comprehensive morphological and functional information of plaques. In this paper, we present an intravascular photoacoustic imaging technique to characterize vulnerable plaques by using optical absorption contrast between normal tissue and atherosclerotic lesions. Specifically, we investigate the feasibility of obtaining intravascular photoacoustic (IVPA) images using a high-frequency intravascular ultrasound (IVUS) imaging catheter. Indeed, the combination of IVPA imaging with clinically available IVUS imaging may provide desired functional and morphological assessment of the plaque. The imaging studies were performed with tissue-mimicking arterial vessel phantoms and excised samples of rabbit artery. The results of our study suggest that catheter-based intravascular photoacoustic imaging is possible, and the combination of IVPA with IVUS has the potential to detect and differentiate atherosclerosis based on both the structure and composition of the plaque.     

Magnetic resonance imaging-based computational modelling of blood flow and nanomedicine deposition in patients with peripheral arterial disease

Peripheral arterial disease (PAD) is generally attributed to the progressive vascular accumulation of lipoproteins and circulating monocytes in the vessel walls leading to the formation of atherosclerotic plaques. This is known to be regulated by the local vascular geometry, haemodynamics and biophysical conditions. Here, an isogeometric analysis framework is proposed to analyse the blood flow and vascular deposition of circulating nanoparticles (NPs) into the superficial femoral artery (SFA) of a PAD patient. The local geometry of the blood vessel and the haemodynamic conditions are derived from magnetic resonance imaging (MRI), performed at baseline and at 24 months post intervention. A dramatic improvement in blood flow dynamics is observed post intervention. A 500% increase in peak flow rate is measured in vivo as a consequence of luminal enlargement. Furthermore, blood flow simulations reveal a 32% drop in the mean oscillatory shear index, indicating reduced disturbed flow post intervention. The same patient information (vascular geometry and blood flow) is used to predict in silico in a simulation of the vascular deposition of systemically injected nanomedicines. NPs, targeted to inflammatory vascular molecules including VCAM-1, E-selectin and ICAM-1, are predicted to preferentially accumulate near the stenosis in the baseline configuration, with VCAM-1 providing the highest accumulation (approx. 1.33 and 1.50 times higher concentration than that of ICAM-1 and E-selectin, respectively). Such selective deposition of NPs within the stenosis could be effectively used for the detection and treatment of plaques forming in the SFA. The presented MRI-based computational protocol can be used to analyse data from clinical trials to explore possible correlations between haemodynamics and disease progression in PAD patients, and potentially predict disease occurrence as well as the outcome of an intervention.     

An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection

Cardiovascular disease is one of the prime causes of mortality throughout the world and there is a need for targeted and effective contrast agents to allow noninvasive imaging of the cholesterol-rich atherosclerotic plaques in arteries. A new, fully synthetic, high-density lipoprotein (HDL)-mimicking MRI contrast agent is developed, which enhances macrophage-rich areas of plaque in a mouse model of atherosclerosis by 94%. Confirmation of the targeting of this nanoparticulate agent is achieved using confocal microscopy by tracking a fluorescent lipid incorporated into the nanoparticle.